World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston
AbbVie at World CDx 2026
Oct 5–8, 2026 Boston, MA ~900 attendees Website
AbbVie takes part in 3 sessions at World CDx 2026 in Boston. Its sessions cover biomarkers that select patients for treatment, including single-cell measures, and the companion diagnostic partnerships behind them. A concrete focus is the strategy for launching biomarker tests worldwide alongside antibody-drug conjugates for cancer.
| Organization | World CDx 2026 Attendance |
|---|---|
AbbVie North Chicago, IL | |
Global pharmaceutical company with medicines in immunology, oncology, neuroscience and eye care, including antibody-drug conjugates for cancer. | Panel Tue Oct 6 2:00pm Single-Cell Becomes a Reality: The Next Generation of Therapy Selection Biomarkers Biomarker discovery & translation Talk Wed Oct 7 11:50am Strategic Considerations for Global Precision Medicine ADC Biomarker Launches Drug–diagnostic commercialization & accessClinical & companion diagnostic development Talk Wed Oct 7 2:10pm From Assay to Asset: How End‑to‑End Companion Diagnostic Partnerships Deliver Strategic Platform Selection, Clinical Development Alignment, & Reliable Execution Clinical & companion diagnostic development |
Instantly find 20 buyers from AbbVie
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by World CDx or its organizers. Submit a correction